Clinical trial
Study of Hepatic Responses in Patients Receiving Direct-acting Anti-HCV Drugs
NCT02532907 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Hepatic Responses in Patients Receiving Direct-acting Anti-HCV Drugs
- Lead sponsor
- University of Colorado, Denver
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2015
- Completion date
- July 10, 2018
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.